| 18th week of 2012 patent applcation highlights part 61 |
| Patent application number | Title | Published |
|---|
| 20120108619 | N1/N2-LACTAM ACETYL-COA CARBOXYLASE INHIBITORS - The invention provides a compound of Formula (I) | 2012-05-03 |
| 20120108620 | FORMS OF RIFAXIMIN AND USES THEREOF - The present invention relates to new rifaximin forms kappa, theta, rifaximin:piperazine cocrystal 1 and rifaximin:piperazine cocrystal 2, methods of making same and to their use in medicinal preparations and therapeutic methods. | 2012-05-03 |
| 20120108621 | PHARMACEUTICAL PREPARATION CONTAINING OXYCODONE AND NALOXONE - The invention concerns a storage stable pharmaceutical preparation comprising oxycodone and naloxone for use in pain therapy, with the active compounds being released from the preparation in a sustained, invariant and independent manner. | 2012-05-03 |
| 20120108622 | PHARMACEUTICAL FORMULATION CONTAINING GELLING AGENT - Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient. | 2012-05-03 |
| 20120108623 | BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN - This present disclosure provides methods of treating pain with beloxepin and/or beloxepin analogs. | 2012-05-03 |
| 20120108624 | TREATMENT OF DYSKINESIA RELATED DISORDERS - Disclosed herein are methods of treating Parkinsons disease while maintaining a low dyskinesia induction profile and methods of reversing dyskinesias comprising administering a therapeutically effective amount of a compound of the invention. The present invention further relates to uses and pharmaceutical compositions of said compounds in the manufacture of medicaments in treating the same. | 2012-05-03 |
| 20120108626 | MULTIDOSE PACKAGE, COURSE AND METHOD OF TREATMENT FOR DELIVERING PREDETERMINED MULTIPLE DOSES OF A PHARMACEUTICAL - A multidose package containing an imiquimod formulation suitable for treating topical conditions includes: a) a dispensing aperture for dispensing the formulation from the package; b) a reservoir containing sufficient formulation to provide two or more doses; c) a metered dosage element for measuring a predetermined dose of the formulation, the element including an inlet from the reservoir and an outlet to the dispensing aperture; and d) an actuating element operating the dosage element so the predetermined dose is delivered to the dispensing aperture; wherein the dose is dispensed without microbial or other contamination or degradation of the formulation in reservoir. A corresponding course of treatment for various maladies includes providing a multidose package containing an imiquimod formulation suitable for the treatment. A corresponding method of treatment of diseases with multiple doses of an imiquimod formulation includes multiple doses provided by a multidose package. | 2012-05-03 |
| 20120108627 | IMIDAZO [4,5-C]QUINOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF TUMORS AND/OR INFLAMMATION - The present invention provides the compounds of formula (I): | 2012-05-03 |
| 20120108628 | INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY - This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling and HGF receptor signaling. More particularly, the invention relates to compounds, compositions and methods for the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions. | 2012-05-03 |
| 20120108629 | New use of neferine - The present invention reveals a new use of neferine. Neferine regulates M8 and V1 subtype of transient receptor potential ion channel (TRPM8 and TRPV1), respectively, in mammalians, including humans, and can be used for preparing medicaments for treating disease related to said ion channel (such as hyperalgesia, Parkinson's disease, painful bladder syndrome, chronic obstructive pulmonary disease, and tumor of skin, prostate, mammary gland, lung, colon, etc). The potency of neferine in the present invention is higher than that of hexahydrothymol. | 2012-05-03 |
| 20120108630 | Hedgehog Pathway Antagonists and Methods of Use - The present disclosure provides for compounds, pharmaceutical preparations, kits and methods for the inhibition of the Hh pathway and the alleviation of cancer and developmental disorders associated with the Hh pathway. | 2012-05-03 |
| 20120108631 | Sulfonamides for the Modulation of PKM2 - The invention relates to sulfonamide compounds and methods for activating PKM2. The compounds and methods are useful in treating or preventing a disease or disorder selected from cancer, cell proliferative disorder, inflammatory disorder, metabolic disorder, and immune system disorder. | 2012-05-03 |
| 20120108632 | PRENYLTRANSFERASE INHIBITORS FOR OCULAR HYPERTENSION CONTROL AND THE TREATMENT OF GLAUCOMA - The invention concerns in one embodiment a method of treating glaucoma or elevated intraocular pressure comprising administering a pharmaceutically effective amount of a composition comprising at least one prenyltransferase inhibitor. In another embodiment, the invention concerns a composition for the treatment of elevated intraocular pressure and glaucoma comprising a pharmaceutically effective amount of a prenyltransferase inhibitor. | 2012-05-03 |
| 20120108633 | INJECTABLE COMPOSITION CONTAINING HYDROXYCHLOROQUINE FOR LOCAL ADMINISTRATION FOR TREATING HEMORRHOIDS - The present invention relates to an injectable composition for local administration for treating hemorrhoids, which contains hydroxychloroquine. Specifically, the composition contains a solution of hydroxychloroquine in physiological saline for injection, together with a local anesthetic and an antioxidant. | 2012-05-03 |
| 20120108634 | FARNESYL PROTEIN TRANSFERASE INHIBITOR COMBINATIONS WITH ANTIESTROGEN AGENTS - The present invention is concerned with combinations of a farnesyl transferase inhibitor and an antiestrogen agent for inhibiting the growth of tumor cells, useful in the treatment of cancer. | 2012-05-03 |
| 20120108635 | Insecticidal Arylpyrrolines - The invention relates to novel arylpyrroline compounds of formula (I) which have excellent insecticidal activity and which can thus be used as an insecticide. | 2012-05-03 |
| 20120108636 | Allosteric Enhancers of th A1 Adenosine Receptor - The present invention provides compounds of formula (I) | 2012-05-03 |
| 20120108637 | Fused Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands - Compounds of formula (I) | 2012-05-03 |
| 20120108638 | PYRIDIN-4-YL DERIVATIVES - The invention relates to pyridine derivatives of Formula (I), wherein A, R | 2012-05-03 |
| 20120108639 | NITROGEN-CONTAINING AROMATIC HETEROCYCLYL COMPOUND - The present invention provides a compound having excellent regulating action on blood lipid level that is represented by the following general formula (I) or a pharmacologically acceptable salt thereof, wherein, in one embodiment, A represents a 5-membered nitrogen-containing aromatic heterocyclyl group; R | 2012-05-03 |
| 20120108640 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS - The present invention relates to methods and compositions for treating neuropathic pain and neuropsychiatric disorders by administering agents that are effective in reducing the effective amount, inactivating, and/or inhibiting the activity of a Na | 2012-05-03 |
| 20120108641 | ANTITUMOR COMBINATION INCLUDING AVE8062 AND SORAFENIB - Combinations comprising AVE8062 and sorafenib are provided which are effective in the treatment of cancers, more particularly of solid tumours. | 2012-05-03 |
| 20120108642 | TRPV1 ANTAGONISTS - The present invention relates to compounds of formula (I) | 2012-05-03 |
| 20120108643 | METHOD OF INCREASING THE EXTENT OF ABSORPTION OF TIZANIDINE - An article and method for increasing the extent of tizanidine absorption in a patient receiving tizanidine therapy. Tizanidine may be administered in the form of an immediate release tablet composition at or around the time food is consumed. The composition may be packaged in a container for distribution. | 2012-05-03 |
| 20120108644 | AGRICULTURAL OR HORTICULTURAL FUNGICIDE COMPOSITION AND ITS USE FOR CONTROLLING PLANT PATHOGENS - The present invention provides a composition in which a fungicidal effect against a cultivated crop infected by a plant pathogen is stable and highly active. An excellent agricultural or horticultural fungicide composition for controlling a plant pathogen is provided by using (a) at least one imidazole compound represented by formula (I): | 2012-05-03 |
| 20120108645 | NOVEL MICROBIOCIDES - Compounds of formula (I) in which the substituents are as defined in claim | 2012-05-03 |
| 20120108646 | RNAi Modulation Of TGF-BETA And Therapeutic Uses Thereof - The present invention concerns methods of treatment using transforming growth factor beta (TGF-beta) modulators. More specifically, the invention concerns methods of treating disorders associated with undesirable TGF-beta signaling, by administering short interfering RNA which down-regulate the expression of TGF-beta, and agents useful therein. | 2012-05-03 |
| 20120108647 | THERAPEUTIC USES OF INHIBITORS OF RTP801L - The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases respiratory conditions and hearing disorders based upon inhibition of the RTP801L gene and/or protein. | 2012-05-03 |
| 20120108648 | MITOCHONDRIAL FUNCTION-IMPROVING AGENT - It is an object of the present invention to provide a novel mitochondrial function-improving agent and a novel PGC-1α expression inducing agent. The present invention provides a mitochondrial function-improving agent and a PGC-1α expression inducing agent each of which comprises a lysine-specific demethylase-1 (LSD-1) inhibitor. | 2012-05-03 |
| 20120108649 | METHODS AND COMPOSITIONS TO PROTECT AQUATIC INVERTEBRATES FROM DISEASE - Compositions and methods of protecting aquatic invertebrates from disease is shown. In one embodiment, dsRNA or antisense RNA to a nucleic acid molecule of the disease-causing microorganism is prepared and delivered to the animal. In another embodiment, a nucleic acid molecule of the disease-causing microorganism is delivered to the animal. In another embodiment, the RNA or nucleic acid molecule is delivered to the animal by replicon particle. In a further embodiment, the protective molecule is delivered to the digestive tract of the animal. Protection from disease is obtained. | 2012-05-03 |
| 20120108650 | MICRO RNA MARKERS AND METHODS RELATED THERETO - The present invention provides methods of diagnosis of Alzheimer's disease including assessing the levels of certain microRNAs in a subject and comparing these to levels in subjects not exhibiting the disease. The identified measurements provide input for improved diagnoses of Alzheimer's disease as compared to certain other forms of dementias, which allows more effective treatment regimens. | 2012-05-03 |
| 20120108651 | GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS AND STATIN RESPONSE, METHODS OF DETECTION AND USES THEREOF - The present invention provides compositions and methods based on genetic polymorphisms that are associated with response to statin treatment (particularly for reducing the risk of venous thrombosis). For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection. | 2012-05-03 |
| 20120108652 | OLIGOMERS - Molecules are provided for inducing or facilitating exon skipping in forming spliced mRNA products from pre-mRNA molecules in cells. The molecules may be provided directly as oligonucleotides or expression products of vectors that are administered to a subject. High rates of skipping can be achieved. High rates of skipping reduce the severity of a disease like Duchene Muscular Dystrophy so that the disease is more like Becker Muscular Dystrophy. This is a severe reduction in symptom severity and mortality. | 2012-05-03 |
| 20120108653 | OLIGOMERS - Molecules are provided for inducing or facilitating exon skipping in forming spliced mRNA products from pre-mRNA molecules in cells. The molecules may be provided directly as oligonucleotides or expression products of vectors that are administered to a subject. High rates of skipping can be achieved. High rates of skipping reduce the severity of a disease like Duchene Muscular Dystrophy so that the disease is more like Becker Muscular Dystrophy. This is a severe reduction in symptom severity and mortality. | 2012-05-03 |
| 20120108654 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR OXIDATIVE STRESS AND RETINITIS PIGMENTOSA - Oxidative damage contributes to cone cell death in retinitis pigmentosa and death of rods, cones, and retinal pigmented epithelial (RPE) cells in ocular oxidative stress related diseases including age-related macular degeneration and retinitis pigmentosa. Oral antioxidants may provide modest benefits, but more efficient ways of preventing oxidative damage are needed. Compositions and methods are provided herein for the prevention, amelioration, and/or treatment of early or late stage ocular disease by increasing the expression or activity of one or more peroxidases in cells of the eye, particularly retinal cells, and further optionally increasing the expression or activity of one or more superoxide dismuatases in the same cells. | 2012-05-03 |
| 20120108655 | Methods of Diagnosing and Treating Carcinomas - Methods of diagnosing a carcinoma include comparing the expression of miRNAs in a sample with a control and determining ratios of expression of miRNAs. Methods of treatment include administering a nucleic acid encoding a miR-375 gene product. Methods of optimizing treatment in a subject include determining expression of an miR21-gene product. | 2012-05-03 |
| 20120108656 | USE OF MICRORNA-199B-5P IN MEDICAL AND DIAGNOSTIC FIELD - This invention concerns the use of MicroRNA-199b-5p in medical and diagnostic fields. Particularly, this invention concerns the use of the miR199b-5p in the anti-cancer therapy and as a histophatological and metastasis marker. | 2012-05-03 |
| 20120108657 | DISEASE-ASSOCIATED PROTEIN - Disclosed are methods and compositions for early diagnosis, monitoring and treatment of retinal dystrophy, age-related macular degeneration, Bardet-Biedel syndrome, Bassen-kornzweig syndrome, best disease, choroidema, gyrate atrophy, congenital amourosis, refsun syndrome, stargardt disease and Usher syndrome. In particular, the invention relates to a protein, termed “Rdcvf1,” that is differentially transcribed and expressed in subjects suffering from retinal dystrophies and the like, such as retinal dystrophy and age-related macular degeneration compared with nonsufferers, antibodies which recognize this protein, and methods for diagnosing such conditions. | 2012-05-03 |
| 20120108658 | OPHTHALMIC COMPOSITION - Disclosed is an ophthalmic composition which is characterized by containing (A) a vitamin A, (B) a polyoxyethylene polyoxypropylene glycol, and (C) an oil component that is selected from the group consisting of castor oil, soybean oil, sesame oil, peanut oil, olive oil, almond oil, wheat germ oil, corn oil, rapeseed oil, sunflower oil, purified lanolin and gel hydrocarbon. | 2012-05-03 |
| 20120108659 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 2012-05-03 |
| 20120108660 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 2012-05-03 |
| 20120108661 | EMULSIFIED COMPOSITION - The emulsion composition of the present invention contains
| 2012-05-03 |
| 20120108662 | COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS - The present application relates to compositions and the treatment of skin disorders, dry skin, protection of skin in inflammatory events and neurological disorders. The present application more particularly discloses the identification of new genes and metabolic pathways involved in skin disorders, which provide novel targets and approaches for treating said disorders and for screening biologically active compounds. The present invention also provides various products and constructs, such as probes, primers, vectors, recombinant cells, which can be used to implement the above methods. The invention may be used to detect or treat various skin disorders, particularly dry and inflammatory skin disorders and neurological disorders, in various subjects, including mammalian subjects, particularly human beings. | 2012-05-03 |
| 20120108663 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA - In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. | 2012-05-03 |
| 20120108664 | TRANSDERMAL DELIVERY OF BENEFICIAL SUBSTANCES EFFECTED BY A HOSTILE BIOPHYSICAL ENVIRONMENT - The present invention generally relates to the transdermal delivery of substances In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed. By creating a hostile biophysical environment, beneficial substances may be delivered, according to certain embodiments, through the stratum corneum of the skin into the body. Beneficial substances include, but are not limited to, pharmaceutical agents, drugs, vitamins, co-factors, peptides, dietary supplements, and others. The beneficial effects disclosed include, for instance, relief of pain and inflammation, prevention and healing of ulcers of the skin, relief of headache, improved sexual function and enjoyment, growth of hair on the scalp, improving muscle size and/or function, removing body fat and/or cellulite, treating cancer, treating viral infections and others. A hostile biophysical environment may also be used in conjunction with systems and methods for increasing local blood flow, according to one set of embodiments. | 2012-05-03 |
| 20120108665 | METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS - We describe methods and compositions for treating ophthalmic conditions associated with angiogenesis, vascular leakage, and/or damage to ganglia. | 2012-05-03 |
| 20120108666 | Treatment of Cell Proliferative Disorders - The invention relates to compounds and their use in treating cell proliferative disorders, more specifically Syk tyrosine kinase-mediated disorders. | 2012-05-03 |
| 20120108667 | HYDROXY CERAMIDES AND ANALOGS THEREOF AND THEIR USE FOR PREVENTING OR TREATING CANCER - Disclosed herein are compounds, compositions, methods of treatment and synthetic methods for making compounds related to Ceramides and the use of Ceramides. | 2012-05-03 |
| 20120108668 | METABOLIC PROFILES - The invention relates to the use of endogenous metabolites to produce a metabolic profile of a disorder or disease in a subject, e.g. an autoimmune disease, in particular rheumatoid arthritis, and the analysis of such metabolic profiles in order to find disturbances in such profiles in a subject which are caused by or correlated with the said diseases or disorders. Such disturbances can be normalised by treatment of the subject with specified compounds, particularly N-(2-chloro-3,4-dimethoxybenzylideneamino)guanidine or an aminoguanidine. | 2012-05-03 |
| 20120108669 | METHOD OF TREATING SLEEP DISORDERS USING EPLIVANSERIN - Method for treating sleep disorders by using eplivanserin Method of providing eplivanserin. Method of managing the risk to allow an effective and safe use of eplivanserin Method of promoting the use of eplivanserin. Article of manufacture and package. | 2012-05-03 |
| 20120108670 | FORMOTEROL TARTRATE PROCESS AND POLYMORPH - A method of preparation of a highly pure salt of R,R-formoterol L-tartrate is disclosed. The process provides the most thermodynamically stable polymorph by recrystallization of a novel polymorph. | 2012-05-03 |
| 20120108671 | CIS 3,4-DIHYDROXY-2-(3-METHYLBUTANOYL)-5-(3-METHYLBUTYL)-4-(4-METHYLPENTAN- OYL)CYCLOPENT-2-EN-1-ONE DERIVATIVES, SUBSTANTIALLY ENANTIOMERICALLY PURE COMPOSITIONS AND METHODS - The present application provides cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives and substantially enantiomerically pure compositions thereof. These derivatives include (+)-(4S,5R)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one, (−)-(4R,5S)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one, and salts and crystals thereof. The application further provides methods of using the disclosed compounds and compositions to activate PPARγ, activate GPR120, inhibit inflammation, and treat conditions responsive to PPARγ modulation, conditions responsive to GPR120 modulation, and metabolic disturbances such as diabetes. | 2012-05-03 |
| 20120108672 | OPHTHALMIC COMPOSITION AND METHOD FOR PREVENTION OF CLOUDINESS/PRECIPITATION - An ophthalmic composition characterized by comprising (A) vitamin A, (B) a polyoxyethylene polyoxypropylene glycol, and at least one component selected from (C) trometamol, (D) polyhydric alcohols, (E) a sugar, (F) phosphoric acid and salt thereof and (G) monovalent neutral salts. | 2012-05-03 |
| 20120108673 | PROCESS FOR ISOLATION OF LUTEIN AND ZEAXANTHIN CRYSTALS FROM PLANT SOURCES - The present invention provides for a process for isolation of carotenoids crystals comprising drying a plant part to obtain a meal and extracting the meal with alcohol at a temperature in the range of about 50° C. to 75° C. to obtain oleoresin. The oleoresin is enriched with alcohol at a temperature in the range of about 25° C. ° C. to 50° C. and hydrolyzed with alcoholic alkali at a temperature in the range of about 70° C. to 80° C. to obtain reaction mixture. The carotenoids crystals are precipitated from the reaction mixture by adding hot water followed by filtering, washing and drying the carotenoids crystals. The present invention also relates to carotenoids crystals comprising lutein and zeaxanthin in the ratios of about 10:1 or 5:1 or 1:1 obtained by a process which comprises mixing an oleoresin rich in lutein and an oleoresin rich in zeaxanthin separately in a ratios ranging from about 80:20 (w/w) to 90:10 (w/w) or about 70:30 (w/w) to 30:70 (w/w) or about 10:90 (w/w) to 20:80 (w/w) and homogenized to obtain a mixed oleoresin. The mixed oleoresin is then hydrolyzed with an alcoholic alkali at a temperature of about 70° C. to 80° C. to obtain a reaction mixture. The carotenoids crystals are precipitated by adding hot water to the reaction mixture to form a precipitate. Carotenoids crystals having lutein and zeaxanthin in a weight ratio of about 10:1 or 5:1 or 1:1 respectively are obtained by filtering, washing and drying the precipitate. | 2012-05-03 |
| 20120108674 | INJECTABLE HYDROGEL FOR THE LONG-TERM SUPPLEMENTATION OF GLYCEROL IN THE SKIN - An injectable hydrogel, includes, in weight, in a physiologically acceptable carrier fluid: 0.01 to 5% of glycerol and 0.1 to 5% of cross-linked hyaluronic acid, or one of the salts thereof; characterized in that the hyaluronic acid or one of the salts thereof is cross-linked by the formation of covalent bonds using bifunctional or polyfunctional molecules, the injectable hydrogel being sterilized in moist heat and having viscoelastic properties such that Tanδ at a frequency of 1 Hz is less than or equal to 1.10. A method for producing the hydrogel, to a kit containing the hydrogel, as well as to the use thereof in dermatology are also described. | 2012-05-03 |
| 20120108675 | PROCESS AND APPARATUS FOR PRODUCING HYDROCARBONS BY HYDROGENATING A TERPENE FEED - The invention relates to a process and an apparatus for producing hydrocarbon components in the presence of a hydrodesulphurization catalyst. The components obtained by the process are suitable for use as fuel composition as such or as an additive in fuel compositions, and in cosmetics or pharmaceutical products. | 2012-05-03 |
| 20120108676 | AEROSOL-MEDIATED PARTICLE SYNTHESIS - Disclosed are aerosol-mediated methods for synthesizing particles for biomedical and drug delivery applications. The method is based on the production of particles from sprayed polymeric micro or nano-droplets obtained by, for example, an air-jet nebulization process that is followed by gelation and/or hardening in a crosslinking fluid, non-solvent, precipitating solvent, or supercritical fluid. | 2012-05-03 |
| 20120108677 | IMINIC MONOMERS AND POLYMERS THEREOF - Disclosed are biocompatible, bioresorbable polymers comprising a plurality of monomeric repeating units containing an imine group, wherein the inclusion of said imine group is effective to lower the melt viscosity, the solution viscosity, or both, compared to the same polymer without an imine group. | 2012-05-03 |
| 20120108678 | BRANCHED COPOLYMERS, COMPOSITIONS AND USES - The present invention relates to a branched copolymer obtainable by an addition polymerisation process and uses and compositions thereof comprising:
| 2012-05-03 |
| 20120108679 | BRANCHED COPOLYMERS, COMPOSITION AND USES - The present invention relates to a branched copolymer comprising a hydrophilic component obtainable by an addition polymerisation process and compositions and uses thereof said copolymer comprising:
| 2012-05-03 |
| 20120108680 | LONG-CHAIN GLYCYL POLYOL TYPE GELATOR AND GEL - A gelator made of an aliphatic oxyglycyl polyol that is capable of forming a gel by a small amount of addition in a pH range from acidic to alkaline regions, and a gel having high environmental compatibility, biocompatibility and biodegradability. A gelator including an aliphatic oxyglycyl polyol of Formula (1) wherein R is a C | 2012-05-03 |
| 20120108681 | Multiple Reactor Chemical Production System - The present invention is a multiple reaction set for the production of chemicals by equilibrium limited reactions utilizing plate-type or extended surface heat exchangers. The heat exchangers cool the reaction products to condense methanol within the reaction products for separation, and to warm incoming feed reactants prior to entrance of the reactants into a reactor utilized for methanol production. The various reactors, heat exchangers, and separators can be formed as separated zones within enclosed vessels, thereby eliminating the need for separately constructed reactors, heat exchangers, and separators. Multi-stream plate-type of extended surface heat exchangers can be utilized to allow efficient cooling and methanol separation. The multiple reaction set can also be used for the recovery of methanol from a waste or purge gas stream utilizing multiple reactors, multiple plate-type or extended surface heat exchangers and multiple separators as a substitute for or in conjunction with a conventional methanol synthesis loop. | 2012-05-03 |
| 20120108682 | PROCESS OF SYNTHESIS GAS CONVERSION TO LIQUID HYDROCARBON MIXTURES USING ALTERNATING LAYERS OF SYNTHESIS GAS CONVERSION CATALYST, HYDROCRACKING AND HYDROISOMERIZATION CATALYST - Disclosed is a process for converting synthesis gas to liquid hydrocarbon mixtures useful in the production of fuels and petrochemicals. The synthesis gas is contacted with at least two layers of synthesis gas conversion catalyst wherein each synthesis gas conversion catalyst layer is followed by a layer of hydrocracking catalyst and hydroisomerization catalyst or separate layers of hydrocracking and hydroisomerization catalysts. The process can occur within a single reactor, at an essentially common reactor temperature and an essentially common reactor pressure. The process provides a high yield of naphtha range liquid hydrocarbons and a low yield of wax. | 2012-05-03 |
| 20120108683 | CATALYST FOR SELECTIVE METHANIZATION OF CARBON MONOXIDE - The invention relates to a catalytic composition and to a process for selective methanization of carbon monoxide in hydrogen- and carbon dioxide-containing streams, wherein the active component used is ruthenium and the support material is a lanthanum-cerium-zirconium oxide, and to the use thereof in fuel cell systems. | 2012-05-03 |
| 20120108684 | COMPACTED POLYELECTROLYTE COMPLEXES AND ARTICLES - A method is described for producing an osmotically compacted polyelectrolyte complex having a first region and a second region, the first region having a greater modulus than the second region. The method comprises contacting an article comprising polyelectrolyte complex to a solution comprising a preferred osmolyte of concentration sufficient to compact said polyelectrolyte complex and terminating the compaction process before the entire article is osmotically compacted. | 2012-05-03 |
| 20120108685 | COMPACTED POLYELECTROLYTE COMPLEXES AND ARTICLES - A method is described for producing an osmotically compacted polyelectrolyte complex having a first region and a second region, the first region having a greater modulus than the second region. The method comprises contacting an article comprising polyelectrolyte complex to a solution comprising a preferred osmolyte of concentration sufficient to compact said polyelectrolyte complex and terminating the compaction process before the entire article is osmotically compacted. | 2012-05-03 |
| 20120108686 | Method For Determining The Performance Of A Superabsorbent Polymer Material - Method for determining the performance of a superabsorbent polymer material by using a virtual model of the superabsorbent polymer material comprising the steps of inputting values of one or more first molecular parameter(s) into the virtual model and calculating the value(s) of one or more first performance output parameter(s) and inputting values of one or more second molecular parameter(s) into the virtual model and calculating the value(s) of one or more second performance output parameter(s) and determining the variation between the value(s) of the one or more first performance output parameter(s) and the value(s) of the one or more second performance output parameter(s). | 2012-05-03 |
| 20120108687 | Processes Using Supercritical Medium To Produce Polymers - Processes for making water-absorbent cross-linked polymers, such as polyacrylic acids/polyacrylates, using supercritical medium; and water-absorbent polymers, e.g. particles thereof, obtained by such processes, where such particles may be porous. | 2012-05-03 |
| 20120108688 | HYDROFLUOROPROPENE BLOWING AGENTS FOR THERMOPLASTICS - The present invention relates to blowing agent compositions comprising the unsaturated halogenated hydroolefin 3,3,3-trifluoropropene (HFO 1243zf) and combinations including primarily 3,3,3-trifluoropropene (HFO 1243zf). The blowing agent compositions are useful in that they provide sufficient plasticization to permit the production of low density insulating thermoplastic foams with improved k-factor. | 2012-05-03 |
| 20120108689 | PROCESS FOR FORMING A POROUS PVA SCAFFOLD USING A PORE-FORMING AGENT - The present invention relates to a process for forming a porous poly(vinyl alcohol) (PVA) scaffold using a pore-forming agent, and more particularly, to a process for forming a porous PVA scaffold using a pore-forming agent, comprising: mixing PVA with the pore-forming agent to form micropores in the PVA scaffold and using an easily decomposable pore-forming agent after the formation of the pores to improve convenience and reduce the processing time in manufacturing the porous PVA scaffold as well as to enable a pore size and porosity to be selected. A process for forming a porous PVA scaffold using a pore-forming agent according to the present invention includes heating to melt the PVA, cooling the melted PVA and mixing the PVA with a heat-decomposable pore-forming agent, repeating the freezing/thawing of the mixed PVA to cure the PVA mixture, and stirring the cured PVA mixture with a hydrochloric acid solution at a high temperature of 65° C. or more to produce foam. | 2012-05-03 |
| 20120108690 | METHOD FOR PRODUCING FLAME-RETARDANT POLYURETHANE FOAM MATERIALS HAVING GOOD LONG-TERM USE PROPERTIES - The subject-matter of the present invention relates to a process for the production of flame-retardant polyurethane foams, preferably for the production of flame-retardant flexible polyurethane foams, from
| 2012-05-03 |
| 20120108691 | LOW DENSITY THERMOPLASTIC ELASTOMERS - A thermoplastic elastomer (TPE) is disclosed which is foamed and has low density by virtue of the use of glass microspheres. | 2012-05-03 |
| 20120108692 | PREPARATION OF FOAM MATERIALS DERIVED FROM RENEWABLE RESOURCES - Monomers and crosslinkers derived from renewable resources that can be used to produce flexible, microporous, open-celled polymeric foam materials having physical characteristics making them suitable for a variety of uses, are disclosed. Monomer compositions derived from renewable resources, and having short curing times for preparing foam materials from high internal phase emulsions are also disclosed. | 2012-05-03 |
| 20120108693 | SEGMENTED POLYARYLENE ETHER BLOCK COPOLYMERS - The present invention relates to polyarylene ether block copolymers according to the general formula A-K-X-K-A, where | 2012-05-03 |
| 20120108694 | METHOD FOR SYNTHESISING A BLOCK COPOLYMER ALLOY HAVING IMPROVED ANTISTATIC PROPERTIES - The invention relates to a method for synthesising a block copolymer alloy including at least one rigid polyamide block PA, including the steps of: a) producing said block copolymer; b) adding, during step a) and to at least a portion of said block copolymer, 0.1 to 30 wt % of at least one organic salt in the molten state relative to the total weight of the alloy, so that the alloy thus obtained has improved antistatic properties and identical mechanical properties when compared to the same polymer produced without adding an organic salt. The invention also relates to a block copolymer alloy having improved antistatic properties and obtained by said method, to the use thereof in a polymer matrix, and to a composition containing same. | 2012-05-03 |
| 20120108695 | POLYMERIZATION REACTOR FOR PRODUCING A SUPER ABSORBENT POLYMER AND METHOD FOR PRODUCING A SUPER ABSORBENT POLYMER USING THE POLYMERIZATION REACTOR - The present invention provides a polymerization reactor for producing a super absorbent polymer comprising: a reaction unit; a monomer composition supply unit being connected to the reaction unit and supplying a monomer composition solution containing a monomer, a photoinitiator, and a solvent; an agitating shaft extended in the reaction unit from one end of the reaction unit connected to the monomer composition supply unit to the other end of the reaction unit; a plurality of agitating blades installed around the agitating shaft; and a light irradiation unit providing light to the monomer composition solution furnished from the monomer composition supply unit, and a method of producing super absorbent polymers by using the same. | 2012-05-03 |
| 20120108696 | O-IMINO-ISO-UREA COMPOUNDS AND POLYMERIZABLE COMPOSITIONS THEREOF - The invention relates to the use of O-imino-iso-urea compounds as source of radicals to polymerizable compositions comprising these O-imino-iso-urea and to new O-imino-iso-urea compounds. The O-lmino-isoureas compounds are compounds of the Formula (I), wherein n is 1, 2, 3 or 4, R | 2012-05-03 |
| 20120108697 | Composition and Polymer - A composition and a polymer are provided. The composition includes the polymer and a melamine derivative. The polymer has a formula of | 2012-05-03 |
| 20120108698 | FRICTION MATERIAL INCLUDING A PLURALITY OF BINDER PARTICLES WITH FRICTION MODIFYING PARTICLES BOUND THERETO - One exemplary embodiment includes a friction material including a base including a plurality of fibers. The base including an engagement surface, and a plurality of binder particles and friction modifying particles at the engagement surface. | 2012-05-03 |
| 20120108699 | Composite Compositions - In one embodiment, the present invention provides an uncured composite composition. The uncured composite composition includes an uncured resin and a triaxial braid. The triaxial braid includes a longitudinal axis, a first bias fiber extending in a first bias direction at a first bias angle to the longitudinal axis, a second bias fiber extending in a second bias direction at a second bias angle to the longitudinal axis, and an axial fiber extending in a direction parallel to the longitudinal axis; wherein the first bias fiber, the second bias fiber, and the axial fiber have a substantially same tow size, and the tow size is in a range of from about 1 k to about 11 k. A cured composite and a method of making the cured composite are also provided. | 2012-05-03 |
| 20120108700 | AIR-DRYING POLYESTER (METH)ACRYLATE RESIN COMPOSITION, STRUCTURE, AND METHOD FOR APPLYING THE RESIN COMPOSITION - An object of the present invention is to provide an air-drying polyester (meth)acrylate resin composition in a curing system of a ketone peroxide curing agent and a cobalt-based curing accelerator, the resin composition being used as a topcoat in the field of civil engineering and construction, and having such good properties as, when coated or stacked, being capable of forming a cured coating film with no bubbles remaining therein due to non-bubbling properties of suppressing the generation of bubbles in the course of the curing reaction and being free from problems related to room-temperature curability such as a retarded gelation time, even after being stored for about one month; a structure coated with the resin composition; and a method for applying the resin composition. | 2012-05-03 |
| 20120108701 | COMPOSITION OF A BLEND OF POLYAMIDE AND POLYESTER RESINS - A resin blend composition of a polyamide resin and a polyester resin is described, which includes a polyamide resin, a polyester resin and an epoxy resin. The resin blend composition can have improved compatibility between the polyamide resin and the thermoplastic polyester resin, and therefore mechanical properties (strength, bending strength, elasticity, abrasion resistance, impact strength), chemical properties (solvent resistance), thermal resistance, dimensional stability, and paintability. | 2012-05-03 |
| 20120108702 | PROCESS FOR THE PREPARATION OF RADIATION CURABLE COMPOSITIONS - The present invention relates to a process for the preparation of radiation curable compositions comprising at least one radiation curable (meth)acrylic copolymer A and at least one (meth)acrylated epoxy compound B, said process comprising:—the preparation of a copolymer P by copolymerization of monomers comprising: (i) from 0.1 to 50 mole % of at least one epoxy (meth)acrylate (a1), and (ii) from 50 to 99.9 mole % of at least one other copolymerizable monomer (m) different from (a1) in the presence of at least one non-copolymerizable epoxy compound (b1) and—further reacting copolymer P thereby obtained and the non-copolymerizable epoxy compound (b1) with at least one carboxylic (meth)acrylate (a3). | 2012-05-03 |
| 20120108703 | SURFACE PROTECTIVE AGENT - The present invention provides a surface protective agent having good hard coating properties and good adhesion properties to metal. | 2012-05-03 |
| 20120108704 | Sulfur Modified Asphalt for Warm Mix Applications - Disclosed herein are an asphalt concrete mixture, an asphalt binder composition, and methods of preparing the related compositions. The asphalt binder compositions include a polyphosphoric acid, a macromolecular polymer having a saturated backbone with macromolecular modifications, sulfur, and non-surfactant additives based on wax chemistry. The compositions are capable of being performance graded and being used in warm mix asphalt applications. | 2012-05-03 |
| 20120108705 | SOY METHYL ESTER POLYSTYRENE BLENDS FOR USE IN CONCRETE - A non-aqueous blend composition for treating a porous material comprising triacylglycerides obtained from vegetable oils and containing a fatty acid component and a polystyrene dissolved in the triacylglycerides to form a blend composition, the polystyrene component being present in the blend composition in an amount of from about 1% to about 40% by weight of the fatty acid component. | 2012-05-03 |
| 20120108706 | WOOD FIBER BOARD AND MANUFACTURING METHOD THEREOF - Provided is a wood fiber board, and a production method thereof, such that the wood fiber board contains no phenolic resin, is simple to produce, and exhibits flexural strength and water resistance comparable to those of wood fiber boards produced by incorporating a phenolic resin. The wood fiber board of the present invention has only wood fibers; a polyacrylamide resin being an amphoteric-ionic resin, which has monomers having cationic groups and monomers having anionic groups at a ratio of 7:3 to 3:7 on a mole ratio basis, and which has a molecular weight ranging from 800,000 to 3,000,000; and cationic paraffin. A method of producing a wood fiber board of the present invention involves preparing a slurry to a solids concentration ranging from 2 to 3 wt % and pH of 3 to 5, and adding only the polyacrylamide resin and paraffin to the slurry. | 2012-05-03 |
| 20120108707 | Wood Material Product and Method for the Production Thereof - The invention relates to a wood material product and a method for producing wood material products from particles containing lignocellulose and adhesives containing formaldehydes, which are intermixed and fed to a forming process after mixing. A zeolite is added to the mixture of adhesives and particles containing lignocellulose. | 2012-05-03 |
| 20120108708 | Performance Graded Sulfur Modified Asphalt Compositions For Super Pave Compliant Pavements - Disclosed herein are an asphalt concrete mixture, an asphalt binder composition, and methods of preparing the related compositions. The asphalt binder compositions include a polyphosphoric acid, a macromolecular polymer having a saturated backbone with macromolecular modifications, and sulfur. The compositions are capable of being performance graded. | 2012-05-03 |
| 20120108709 | NOVEL STERICALLY HINDERED AMINE LIGHT STABILIZERS - The instant invention pertains to sterically hindered amine Night stabilizers (HALS) with low basicity at the nitrogen atom and high thermal stability. They are characterized by their spiro- substitution in the 4-position of the tetramethylpiperidine dine ring (Spiro-NOR-HALS). These compounds are particularly effective in stabilizing polymers, especially thermoplastic polyolefins, against the deleterious effects of oxidative, thermal and actinic radiation. The compounds are also particularly effective in stabilizing acid catalyzed and ambient cured coatings systems. They are particularly useful when high processing temperatures are additional required. | 2012-05-03 |
| 20120108710 | POLYAMIDE FIBERS WITH DYEABLE PARTICLES AND PRODUCTION THEREOF - The novel polyamide fibers with dyeable particles comprise 80% to 99.95% by weight of polyamide, 0.05% to 20% by weight of dyeable particles and 0% to 19.95% by weight of added substances, the % by weight summing to 100%. | 2012-05-03 |
| 20120108711 | STABILIZERS - N-substituted Macrocyclic Triazine-HALS Stabilizers. | 2012-05-03 |
| 20120108712 | PHENYLPHOSPHONATE FLAME RETARDANT COMPOSITIONS - The present invention relates to flame retardant polymer compositions which comprise mixtures of melamine or guanidine phenylphosphonates and mixtures with 2,2,6,6-tetraalkyl-piperidines. The mixtures are especially useful for the manufacture of flame retardant compositions based on thermoplastic polymers. | 2012-05-03 |
| 20120108713 | BOROPHOSPHATE, BORATE PHOSPHATE, AND METAL BOROPHOSPHATE AS NOVEL FLAME PROOFING ADDITIVES FOR PLASTICS - The present invention relates to a mixture comprising at least one plastic K and from 0.1 to 50% by weight, based on the entire mixture, of at least one compound A selected from the group consisting of borophosphates, borate phosphates, metalloborophosphates, and mixtures thereof, to a process for the production of said mixture, and to the use of said mixture as flame retardant. | 2012-05-03 |
| 20120108714 | NONWOVEN AND YARN POLYPROPYLENE WITH ADDITIVATION - A process to produce improved polypropylene nonwovens or yarns by extruding a mixture of polypropylene(s) and beta nucleating agent(s), or in the alternative, certain clarifiers, to form the improved polypropylene filaments. | 2012-05-03 |
| 20120108715 | POLYESTER COMPOSITIONS CONTAINING CYCLOBUTANEDIOL HAVING A CERTAIN COMBINATION OF INHERENT VISCOSITY AND HIGH GLASS TRANSITION TEMPERATURE AND ARTICLES MADE THEREFROM - Described are polyester compositions comprising at least one polyester which comprises terephthalic acid residues, 2,2,4,4-tetramethyl-1,3-cyclobutanediol, and 1,4-cyclohexanedimethanol, wherein the inherent viscosity and the Tg of the polyester provides for certain polyester properties. The polyesters may be manufactured into articles such as fibers, films, bottles or sheets. | 2012-05-03 |
| 20120108716 | FLAME RETARDANT AGENT FOR THERMOPLASTIC RESIN AND FLAME RETARDANT RESIN COMPOSITION - A flame retardant agent for a thermoplastic resin, which enables the thermoplastic resin containing the flame retardant agent to keep its viscous property, to be made into a fiber readily, and to exhibit flame retardant effect even when ammonium dihydrogen phosphate is contained in the flame retardant agent as a non-halogen flame retardant component. Also disclosed is a flame retardant resin composition containing the flame retardant agent. Specifically, the flame retardant agent for a thermoplastic resin comprises ammonium dihydrogen phosphate, potassium hydroxide, glycerin and urea, wherein the potassium hydroxide is contained in an amount of 10 to 70 parts by weight, glycerin is contained in an amount of 0.1 to 4.0 parts by weight, and urea is contained in an amount of 1 to 9 parts by weight relative to 100 parts by weight of ammonium dihydrogen phosphate. | 2012-05-03 |
| 20120108717 | INK COMPOSITION FOR FLEXO PRINTING - An ink composition for flexo printing contains a dye type colorant in order to precisely print. The ink composition for flexo printing includes about 1 to 40 wt. % of a colorant, about 5 to 40 wt. % of a binder, about 20 to 95 wt. % of a solvent and a remainder of an additive, wherein the wt. % of the colorant, the binder, the solvent and the additive is based on a total weight of the ink composition. | 2012-05-03 |
| 20120108718 | ORGANOSILICON COMPOUND AS WELL AS RUBBER COMPOSITION, TIRE PRIMER COMPOSITION, PAINT COMPOSITION AND ADHESIVE USING THE SAME - This invention relates to an organosilicon compound having a cyclic structure with nitrogen atom and silicon atom, and one or more sulfur atoms in its molecule, and having a bonding side of one or more groups having as small steric hindrance to silicon atom, a rubber composition formed by compounding an inorganic filler (B) and the organosilicon compound (C) into a rubber component (A) consisting of natural rubber and/or diene-based synthetic rubber, and a tire using such a rubber composition. | 2012-05-03 |
| 20120108719 | COIL-COATED SPECTRALLY SELECTIVE COATINGS ON COPPER OR ALUMINUM WITH PIGMENTS MODIFIED BY AMINOSILANE - The invention relates to TSSS and TISS coatings applied by coil-coating onto substrates of copper or aluminum. Inorganic pigments functionalized by aminosilane are used for making paints, which after the coil-coating onto the substrate form the coatings. For the functionalization the pigment is dispersed in a solution of an aminosilane in a solvent or a mixture of a solvent and a binder without an addition of a non-aminosilane dispersing agent with or without subsequent grinding and use of 0.05-30% of aminosilane on pigment. An aromatic, aliphatic, cycloaliphatic, ketone, ester, ether or alcohol compound or a mixture thereof can be used as the solvent. A silicone-polyester, polyurethane or fluoropolymer can be used as the binder. | 2012-05-03 |
